Armata Pharmaceuticals is a Hold until Phase 3 AP-SA02 data, given a funding-dependent profile and limited margin for error.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results